Therefore, the sustainably high concentrations of COL4A1 in our patients may indicate the persistence of the SSc-associated vasculopathy after AHSCT, despite improvement of fibrosis, as previously reported [14]. The gene discussed is COL4A1; the disease is vascular disorder.